Associate Medical Director, Clinical Development

Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia  OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit  www.tonixpharma.com  and follow the Company on  LinkedIn  and  X . *Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Associate Medical Director, Clinical Development will play a key role in advancing clinical programs by contributing to clinical strategy, study design and execution, data interpretation, and development of clinical and regulatory documents. Working cross-functionally with Clinical Operations, Biostatistics, Regulatory Affairs, Pharmacovigilance, and other teams, this individual will help translate scientific insights into strong clinical evidence and meaningful program decisions. This individual contributor role offers significant ownership and the opportunity to influence clinical development strategy while working closely with cross-functional leaders. Essential Functions Provide scientific leadership for and contribute to the clinical development strategy and plans for vaccine and prophylactic monoclonal antibody candidates from early-stage development through later-stage clinical studies. Lead and support the design, implementation, execution, and interpretation of Phase 1–3 clinical trials, as applicable. Author clinical study protocols, protocol amendments, informed consent materials, clinical study reports, investigator brochures, statistical analysis plans, and other clinical and regulatory documents. Provide scientific input into study objectives, endpoints, eligibility criteria, schedules of assessments, immunogenicity evaluations, and exploratory biomarker strategies. Review emerging clinical data to evaluate safety, tolerability, immunogenicity, efficacy, and overall benefit-risk. Lead ongoing medical and scientific data review, including review of listings, tables, figures, laboratory results, adverse events, protocol deviations, and other clinical trial data. Partner closely with Biostatistics and Data Management on data analysis, interpretation, and presentation. Work with Clinical Operations to support high-quality study execution, including investigator and site engagement, study training, enrollment strategies, and resolution of scientific or clinical study issues. Conduct field assessments of clinical trial progress, including travel to investigative sites and endemic areas, as needed, to evaluate study execution, patient populations, and enrollment of appropriate high-risk populations. Collaborate with laboratory partners on immunologic assays and interpretation of humoral and cellular immune-response data, as appropriate to the program. Contribute to regulatory submissions and interactions with regulatory authorities, including briefing documents, responses to information requests, and clinical sections of INDs/BLAs or other applicable submissions. Support preparation of abstracts, posters, presentations, manuscripts, and other scientific communications describing clinical program results. Monitor relevant scientific literature, competitive programs, regulatory guidance, epidemiology, and advances in vaccinology and infectious diseases. Develop effective relationships with investigators, key opinion leaders, external experts, CROs, laboratories, and other development partners. Contribute to cross-functional program and study teams and communicate clinical findings, risks, and recommendations clearly to internal stakeholders. Serve as a clinical development scientific lead for assigned studies or programs, integrating clinical, operational, statistical, safety, and regulatory perspectives to support program-level decision-making. Maintain high standards of scientific rigor, data integrity, GCP compliance, and patient safety. Necessary Skills and Abilities Strong scientific foundation in vaccinology, immunology, infectious diseases, or a related scientific or medical discipline. Ability to critically analyze complex clinical and scientific datasets and translate findings into clear conclusions and recommendations. Excellent organizational skills with the ability to manage multiple priorities and deliver high-quality work within timelines. Strong interpersonal and collaboration skills, with the ability to work effectively across scientific, clinical, operational, and regulatory functions. Comfortable operating in a fast-paced biopharmaceutical environment, with the ability to roll up your sleeves, work hands-on, and adapt as priorities evolve Hig